These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8771732)

  • 41. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biological characteristics of 3 new substrains of laboratory mice used in evaluating the quality of pertussis vaccines].
    Mats AN; Lifshits IuI; Levina LA; Chernomaz VD; Abaĭkin MK
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):78-82. PubMed ID: 3716691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The patterns of the corrective action of a natural immunomodulator on the secondary immunological defect caused by a corpuscular pertussis vaccine].
    Semenova IB; Akatov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (5):57-9. PubMed ID: 7879484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characteristics of the immune response to a single peroral administration of different doses of corpuscular pertussis vaccine].
    Zakharova NS; Salov VF; Vlasov GS; Shepeleva IB; Sergeeva GS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):76-81. PubMed ID: 2859723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of pertussis vaccine on the functional activity of the peritoneal and splenic macrophages in 2 mouse strains genetically differing by the intensity of their immune response].
    Taranov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):80-3. PubMed ID: 4050220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative characteristics of the toxic properties of the whooping cough microbes].
    Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):111-6. PubMed ID: 173120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses to pertussis vaccines and disease.
    Edwards KM; Berbers GA
    J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The evaluation of the mutagenic activity of pertussis vaccinal preparations].
    Bolgareva GM; Krivtsova EK; Revazova IuA; Zakharova NS; Bazhanova IG; Remova TN; Shmeleva EI; Mertsalova NU; Sukhinova EE; Revazova ES
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (7-8):42-5. PubMed ID: 1466172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nonspecific effect of pertussis vaccine on the immunologic reactivity of mice].
    Prilepin NA; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jan; (1):59-62. PubMed ID: 7189629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The modified leukocytosis promoting factor (LPF)-test: a valuable supplement to the mouse weight gain (MWG)-test in toxicity control of whole cell pertussis vaccine.
    van Straaten-van de Kappelle I; Wiertz EJ; Marsman FR; Borsboom DJ; van de Donk HJ; Kreeftenberg JG
    Biologicals; 1992 Dec; 20(4):277-82. PubMed ID: 1305404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Stimulation of postradiation regeneration of erythropoiesis in mice with Bordetells pertussis vaccine].
    Khorobrykh VV; Sanin AV; Barteneva NS; Snegireva AE
    Biull Eksp Biol Med; 1983 Aug; 96(8):94-7. PubMed ID: 6882913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on culture conditions of Bordetella pertussis and relationship to immunogenicity of vaccines.
    Bellalou J; Relyveld EH
    Ann Microbiol (Paris); 1984; 135B(1):101-10. PubMed ID: 6095715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.
    Peppoloni S; Pizza M; De Magistris MT; Bartoloni A; Rappuoli R
    Physiol Chem Phys Med NMR; 1995; 27(4):355-61. PubMed ID: 8768791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the carbohydrate binding and ADP-ribosyltransferase activities of chemically detoxified pertussis toxins.
    Oh H; Kim BG; Nam KT; Hong SH; Ahn DH; Choi GS; Kim H; Hong JT; Ahn BY
    Vaccine; 2013 Jun; 31(29):2988-93. PubMed ID: 23664992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R; Daggard G; Mukkur T
    J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Purification and properties of Bordetella pertussis toxin].
    Gureeva AA; Grigorian GIu; Rybin VO; Pereverzev NA; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):32-7. PubMed ID: 3529763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.